Celldex Shares Pull Back After Barzolvolimab Enrollment Milestone
Markets Daniel Marsh

Celldex Shares Pull Back After Barzolvolimab Enrollment Milestone

Celldex Therapeutics shares retreated about 4% in premarket trading Thursday, giving back some of the prior session's 24% surge. The biotech completed patient enrollment for two key Phase 3 studies of its mast cell inhibitor barzolvolimab six months early.

CLDX
Figure Technology Shares Rally Ahead of Q4 Earnings Report
Earnings James Calloway

Figure Technology Shares Rally Ahead of Q4 Earnings Report

Figure Technology Solutions shares advanced premarket Thursday, building on Wednesday's 16.5% surge as investors await fourth-quarter earnings after the close.

FIGR
Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets
Regulation James Calloway

Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets

Hims & Hers Health shares held steady premarket following disclosures of an SEC probe and a patent lawsuit from Novo Nordisk. Analysts at BTIG and Citi downgraded the stock, citing regulatory risks.

HIMS NVO
TeraWulf Gains Ahead of Q4 Report, Capacity Expansion in Focus
Earnings James Calloway

TeraWulf Gains Ahead of Q4 Report, Capacity Expansion in Focus

TeraWulf Inc shares edged higher in premarket trading Thursday ahead of its fourth-quarter earnings release, following significant gains earlier in the week. Analysts anticipate $43.55 million in revenue.

WULF
HP Shares Gain Premarket Despite Memory Cost Pressures and Cautious Outlook
Earnings James Calloway

HP Shares Gain Premarket Despite Memory Cost Pressures and Cautious Outlook

HP Inc. shares edged higher in premarket trading following a quarterly earnings beat, though the company cautioned about increasing memory chip costs and U.S. trade regulations. Management maintained its full-year outlook but expects results at the lower end of its forecast range.

HPQ DELL XLK
Palantir Shares Gain Amid Insider Sales, AI Sector Scrutiny
Markets Daniel Marsh

Palantir Shares Gain Amid Insider Sales, AI Sector Scrutiny

Palantir Technologies shares advanced over 4% Wednesday, closing at $134.19, as the market parsed recent insider transactions and broader sentiment toward AI-focused software names.

PLTR NVDA CRM
Tesla Shares Dip Amid Robotaxi Permit Gap, Insider Sale Filing
Technology Sarah Chen

Tesla Shares Dip Amid Robotaxi Permit Gap, Insider Sale Filing

Tesla shares declined 2.9% to $417.40 as regulatory filings revealed no autonomous test miles in California for 2025 and a director's planned stock sale. The company also faces a hiring lawsuit and weaker European sales.

TSLA BYD NVDA NVS
Navitas Semiconductor Holds Gains After Revenue Outlook, CFO Transition
Earnings James Calloway

Navitas Semiconductor Holds Gains After Revenue Outlook, CFO Transition

Navitas Semiconductor shares stabilized in premarket trading after a sharp 20% rally, driven by an upbeat first-quarter revenue forecast and the announcement of its CFO's upcoming departure.

NVTS IFNNY WOLF ON
Bitmine Immersion Rises on Ether Rally, Eyes Inflation Data
Crypto Sarah Chen

Bitmine Immersion Rises on Ether Rally, Eyes Inflation Data

Bitmine Immersion Technologies shares advanced in Thursday's premarket session, extending gains after a 10.6% jump. The move aligns with a rally in Ethereum, which climbed 6.7% to $2,067, lifting stocks tied to digital assets.

BMNR
Circle Shares Dip After Earnings Surge, USDC Growth in Focus
Crypto Sarah Chen

Circle Shares Dip After Earnings Surge, USDC Growth in Focus

Circle Internet Group shares retreated slightly in premarket trading after a sharp post-earnings rally. The USDC issuer reported a 77% year-over-year revenue jump to $770 million for Q4.

CRCL
Exxon Shares Slip as Oil Volatility, Broader Market Moves Set Tone
Markets Daniel Marsh

Exxon Shares Slip as Oil Volatility, Broader Market Moves Set Tone

Exxon Mobil shares declined 2.44% to $147.28, underperforming peers as oil prices fluctuated. The broader market rose following a Supreme Court decision on tariffs.

XOM CVX COP USO
AppLovin Faces Ongoing SEC Probe While Eyeing Social Platform Expansion
Regulation James Calloway

AppLovin Faces Ongoing SEC Probe While Eyeing Social Platform Expansion

AppLovin shares gained 1.6% on Friday despite confirmation of an ongoing SEC investigation. Investors are weighing regulatory risks against the company's potential expansion into social networking.

APP